William J Tester
Overview
Explore the profile of William J Tester including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
484
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Dimou A, Non L, Chae Y, Tester W, Syrigos K
PLoS One
. 2014 Sep;
9(9):e107677.
PMID: 25232729
Objectives: MET is a receptor present in the membrane of NSCLC cells and is known to promote cell proliferation, survival and migration. MET gene copy number is a common genetic...
12.
Dutcher J, Neuberg D, Atkins M, Tester W, Wadler S, Stewart J, et al.
J Interferon Cytokine Res
. 2014 Jan;
34(5):376-84.
PMID: 24433038
Interleukin-1 (IL-1) is a cytokine critical to inflammation, immunological activation, response to infection, and bone marrow hematopoiesis. Cyclophosphamide downmodulates immune suppressor cells and is cytotoxic to a variety of tumors....
13.
Lautenschlaeger T, George A, Klimowicz A, Efstathiou J, Wu C, Sandler H, et al.
Oncologist
. 2013 Jun;
18(6):685-6.
PMID: 23728940
Background: From 1988 to 1999, the Radiation Therapy Oncology Group (RTOG) conducted four prospective studies (8802, 8903, 9506, 9706) of patients with clinical stage T2-4a muscle-invasive bladder cancer. Treatment was...
14.
Lemma G, Lee J, Aisner S, Langer C, Tester W, Johnson D, et al.
J Clin Oncol
. 2011 Apr;
29(15):2060-5.
PMID: 21502559
Purpose: The purpose of this study was to evaluate the impact of carboplatin and paclitaxel in patients with advanced previously untreated thymoma and thymic carcinoma. Patients And Methods: We conducted...
15.
Ramalingam S, Perry M, La Rocca R, Rinaldi D, Gable P, Tester W, et al.
Cancer
. 2008 May;
113(3):542-6.
PMID: 18512224
Background: The purpose of this study was to compare the outcomes between elderly (aged > or = 70 years) patients treated with paclitaxel on a weekly basis and with carboplatin...
16.
Belani C, Ramalingam S, Perry M, LaRocca R, Rinaldi D, Gable P, et al.
J Clin Oncol
. 2008 Jan;
26(3):468-73.
PMID: 18202422
Purpose: To compare the efficacy and safety of weekly paclitaxel in combination with carboplatin administered every 4 weeks to the standard regimen of paclitaxel and carboplatin administered every 3 weeks...
17.
Shipley W, Kaufman D, Tester W, Pilepich M, Sandler H
Cancer
. 2003 Apr;
97(8 Suppl):2115-9.
PMID: 12673704
In the United States, radical cystectomy is viewed as the gold standard and, with few exceptions, is the only treatment recommended for patients with invasive bladder cancer. In many areas...